GENP.F Stock Overview

Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with focus on nutraceuticals and pharmaceuticals in Canada. More details

GENP.F fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has less than 1 year of cash runway

Does not have a meaningful market cap ($4M)

Makes less than USD$1m in revenue (CA$6K)

Negative shareholders equity

+ 2 more risks

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Genix Pharmaceuticals Corporation Competitors

Nevis Brands

OTCPK:NEVI.F

US$1.8m

PMGC Holdings

NasdaqCM:ELAB

US$2.3m

Shineco

NasdaqCM:SISI

US$13.0m

Healthy Extracts

OTCPK:HYEX

US$4.5m

Price History & Performance

Summary of share price highs, lows and changes for Genix Pharmaceuticals
Historical stock prices
Current Share Price	CA$0.04
52 Week High	CA$0.047
52 Week Low	CA$0.014
Beta	-0.50
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	-70.99%
5 Year Change	n/a
Change since IPO	-78.25%

Recent updates

Shareholder Returns

	GENP.F	US Personal Products	US Market
7D	0%	-4.7%	-2.2%
1Y	n/a	-32.0%	9.5%

Return vs Industry: Insufficient data to determine how GENP.F performed against the US Personal Products industry.

Return vs Market: Insufficient data to determine how GENP.F performed against the US Market.

Price Volatility

Is GENP.F's price volatile compared to industry and market?
GENP.F volatility
GENP.F Average Weekly Movement	n/a
Personal Products Industry Average Movement	8.2%
Market Average Movement	6.4%
10% most volatile stocks in US Market	17.4%
10% least volatile stocks in US Market	3.4%

Stable Share Price: GENP.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine GENP.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1993	n/a	Sina Pirooz	www.genixpharm.com

Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with focus on nutraceuticals and pharmaceuticals in Canada. The company develops Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product; Renochlor, a dietary supplement to support kidney health; and Sucanon, a herbal health supplement to manage blood sugar levels and enhance insulin sensitivity in non-insulin dependent adults. It also markets and sells nutraceuticals and pharmaceutical products, such as bee propolis capsules, calcium liquid softgels, seal oil softgels, marine lipid softgels, Lecithin softgels, fish oil softgels, EPO softgels, and spirulina powder, as well as eye ointments and drops.

Genix Pharmaceuticals Corporation Fundamentals Summary

How do Genix Pharmaceuticals's earnings and revenue compare to its market cap?
GENP.F fundamental statistics
Market cap	US$2.61m
Earnings (TTM)	-US$3.00m
Revenue (TTM)	US$4.17k

627.2x

P/S Ratio

-0.9x

P/E Ratio

Is GENP.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GENP.F income statement (TTM)
Revenue	CA$5.67k
Cost of Revenue	CA$1.76k
Gross Profit	CA$3.91k
Other Expenses	CA$4.08m
Earnings	-CA$4.08m

Last Reported Earnings

Apr 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.069
Gross Margin	68.99%
Net Profit Margin	-72,000.00%
Debt/Equity Ratio	-51.5%

How did GENP.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/09/14 23:24
End of Day Share Price	2024/06/17 00:00
Earnings	2024/04/30
Annual Earnings	2023/10/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Genix Pharmaceuticals Corporation is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Genix Pharmaceuticals OTCPK:GENP.F Stock Report